US Pharma MarketingThe post Zimmer Biomet to acquire iovera device from Pacira for $140m appeared first on Medical Device Network.
Zimmer Biomet to acquire iovera device from Pacira for $140m
Zimmer Biomet has signed an agreement to acquire US-based Pacira BioSciences’ iovera drug-free medical device for up to $140m. The milestone payments may be achieved up to and through 31 December 2031. The iovera system alleviates pain by applying focused cold therapy to targeted nerves, temporarily preventing them from transmitting pain signals. Credit: PeopleImages/Shutterstock.com. Zimmer Biomet has signed an agreement to acquire US-based Pacira BioSciences’ iovera drug-free medical device for up to $140m. The deal includes an upfront payment of $70m to Pacira, with the potential for up to $70m more in future revenue-based milestone payments. Combine business intelligence and…
Zimmer Biomet has signed an agreement to acquire US-based Pacira BioSciences’ iovera drug-free medical device for up to $140m.
Source: Medical Device Network